Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

2.58
Delayed Data
As of Feb 17
 +0.04 / +1.57%
Today’s Change
0.67
Today|||52-Week Range
2.67
+10.73%
Year-to-Date

Today’s Trading

Previous close2.54
Today’s open2.54
Day’s range2.48 - 2.58
Volume841,234
Average volume (3 months)809,067
Market cap$400.1M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+48.15%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+72.28%
P/E ratioNM
Price/Sales3.88
Price/Book5.96

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc+0.05+0.38%
LMATLeMaitre Vascular In...+0.61+2.63%
CERSCerus Corp+0.13+3.00%
ELOSSyneron Medical Ltd+0.05+0.51%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$45.7M
Annual profit (last year)-$20.7M
Net profit margin-45.25%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Robert F. Apple
Chief Financial Officer &
Senior Vice President
Fred M. Powell
Corporate headquarters
Ewing, New Jersey

Forecasts


Search for Jobs